PA8634501A1 - Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica - Google Patents
Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeuticaInfo
- Publication number
- PA8634501A1 PA8634501A1 PA20058634501A PA8634501A PA8634501A1 PA 8634501 A1 PA8634501 A1 PA 8634501A1 PA 20058634501 A PA20058634501 A PA 20058634501A PA 8634501 A PA8634501 A PA 8634501A PA 8634501 A1 PA8634501 A1 PA 8634501A1
- Authority
- PA
- Panama
- Prior art keywords
- group
- alquilideno
- rent
- hydrogen atom
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
COMPUESTO QUE RESPONDE A LA FORMULA I: EN LA CUAL: N PUEDE TOMAR UN VALOR DE 1 A 6; -(C) N- REPRESENTA UN GRUPO ALQUILIDENO -C1-6, R1 REPRESENTA * UN ATOMO DE HIDROGENO * UN ATOMO DE ALQUILO -C1-6 R2 REPRESENTA * UN ATOMO DE HIDROGENO * UN ATOMO DE ALQUILO -C1-6 O CICLOALQUILO -C3-6 EVENTUALMENTE SUBSTITUIDO POR 1 A 4 SUBSTITUYENTES; B REPRESENTA * NR3R4, -R3 Y R4 REPRESENTA, INDEPENDIENTEMENTE ENTRE SI, UN GRUPO ALQUILO-C1-6, UN ATOMO DE HIDROGENO; O - R3 Y R4 REPRESENTA JUNTOS, UN GRUPO ALQUILIDENO-C1-6, UN GRUPO ALQUILIDENO-C2-8, UN GRUPO ALQUILIDENO-C1-3 -O-ALQUILIDENO-C1-3, DONDE R5 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO -C1-3 Y ALQUILZARBONILO -C1-6 PUEDEN SER SUBSTITUIDO; O * UN AMINOACIDO, UNIDO POR MEDIO DE UN CARBONO AL GRUPO -NR1-(C) N-, TAL COMO AZIRIDINA, AZETIDINA, PIRROLIDINA; Y EL ATOMO DE NITROGENO ESTA EVENTUALMENTE SUBSTITUIDO APLICACION EN TERAPEUTICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0405607A FR2870846B1 (fr) | 2004-05-25 | 2004-05-25 | Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8634501A1 true PA8634501A1 (es) | 2006-05-16 |
Family
ID=34944870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20058634501A PA8634501A1 (es) | 2004-05-25 | 2005-05-25 | Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica |
Country Status (41)
Country | Link |
---|---|
US (3) | US7833999B2 (es) |
EP (1) | EP1753725B1 (es) |
JP (1) | JP4861979B2 (es) |
KR (1) | KR101176675B1 (es) |
CN (1) | CN1956962B (es) |
AR (1) | AR050250A1 (es) |
AU (1) | AU2005250197B2 (es) |
BR (1) | BRPI0511581A (es) |
CA (1) | CA2565293C (es) |
CR (1) | CR8735A (es) |
CY (1) | CY1114240T1 (es) |
DK (1) | DK1753725T3 (es) |
DO (1) | DOP2005000103A (es) |
EA (1) | EA010234B1 (es) |
EC (1) | ECSP067020A (es) |
ES (1) | ES2407140T3 (es) |
FR (1) | FR2870846B1 (es) |
GT (1) | GT200500126A (es) |
HK (1) | HK1106229A1 (es) |
HN (1) | HN2005000239A (es) |
HR (1) | HRP20130431T1 (es) |
IL (1) | IL179021A (es) |
JO (1) | JO2877B1 (es) |
MA (1) | MA28720B1 (es) |
MX (1) | MXPA06013629A (es) |
MY (1) | MY148980A (es) |
NI (1) | NI200600279A (es) |
NO (1) | NO338104B1 (es) |
NZ (1) | NZ551509A (es) |
PA (1) | PA8634501A1 (es) |
PE (1) | PE20060273A1 (es) |
PL (1) | PL1753725T3 (es) |
PT (1) | PT1753725E (es) |
SI (1) | SI1753725T1 (es) |
SV (1) | SV2006002126A (es) |
TN (1) | TNSN06356A1 (es) |
TW (1) | TWI360540B (es) |
UA (1) | UA84771C2 (es) |
UY (1) | UY28917A1 (es) |
WO (1) | WO2005118547A1 (es) |
ZA (1) | ZA200609820B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2870846B1 (fr) * | 2004-05-25 | 2006-08-04 | Sanofi Synthelabo | Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique |
EP1790646A1 (fr) * | 2005-11-24 | 2007-05-30 | Sanofi-Aventis | Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3. |
ES2436146T3 (es) | 2007-11-13 | 2013-12-27 | Taisho Pharmaceutical Co., Ltd | Derivados de fenilpirazol |
TW201039822A (en) | 2009-02-06 | 2010-11-16 | Taisho Pharmaceutical Co Ltd | Dihydroquinolinone derivatives |
PL2445899T3 (pl) * | 2009-06-26 | 2017-08-31 | Sanofi | Nowe sole fumaranowe antagonisty receptora histaminy H3 |
AR080375A1 (es) * | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida |
JP6098892B2 (ja) | 2011-12-08 | 2017-03-22 | 大正製薬株式会社 | フェニルピロール誘導体 |
EP2799436A4 (en) | 2011-12-27 | 2015-07-01 | Taisho Pharmaceutical Co Ltd | PHENYLTRIAZOLDERIVAT |
EP2647377A1 (en) | 2012-04-06 | 2013-10-09 | Sanofi | Use of an h3 receptor antagonist for the treatment of alzheimer's disease |
JP2016529307A (ja) * | 2013-09-09 | 2016-09-23 | サノフイ | アルツハイマー病の処置に使用するためのh3受容体アンタゴニスト |
CN110642854A (zh) * | 2019-11-20 | 2020-01-03 | 成都克莱蒙医药科技有限公司 | 一种稠环化合物的多晶型、其组合物、制备方法及其应用 |
WO2022113008A1 (en) | 2020-11-27 | 2022-06-02 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029273A1 (en) * | 1993-06-09 | 1994-12-22 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
GB9508622D0 (en) * | 1995-04-28 | 1995-06-14 | Pfizer Ltd | Therapeutic agants |
HUP9901190A3 (en) * | 1996-02-09 | 2002-05-28 | Black James Foundation | Sulfonamide derivatives of imidazole, process for producing them and pharmaceutical compositions containing them |
HUP0101137A3 (en) | 1998-04-10 | 2003-03-28 | Japan Tobacco Inc | Anticoagulant amidines and their pharmaceutical use |
AU5155500A (en) | 1999-05-24 | 2000-12-12 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
ATE295362T1 (de) | 2001-01-02 | 2005-05-15 | Hoffmann La Roche | Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten |
EP1379493A2 (en) * | 2001-03-23 | 2004-01-14 | Eli Lilly and Company | Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
JP2003192660A (ja) * | 2001-12-26 | 2003-07-09 | Bayer Ag | 尿素誘導体 |
WO2003055848A2 (en) * | 2001-12-26 | 2003-07-10 | Bayer Healthcare Ag | Urea derivatives as vr1- antagonists |
WO2003076527A1 (fr) | 2002-03-08 | 2003-09-18 | Sakata Inx Corp. | Pigment traite, utilisation associee et compose de traitement de pigments |
GB0206033D0 (en) | 2002-03-14 | 2002-04-24 | Pfizer Ltd | Compounds useful in therapy |
JP4619786B2 (ja) * | 2002-08-29 | 2011-01-26 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 炎症性、アレルギー性及び増殖性疾患の治療において糖質コルチコイドミメティックスとして使用するための3−(スルホンアミドエチル)−インドール誘導体 |
CN1886393A (zh) | 2003-10-08 | 2006-12-27 | 沃泰克斯药物股份有限公司 | 含有环烷基或吡喃基基团的atp-结合弹夹转运蛋白的调控剂 |
EP1679309A4 (en) | 2003-10-24 | 2007-03-28 | Ono Pharmaceutical Co | ANTISTRESS MEDICAMENT AND ITS MEDICAL USE |
FR2870846B1 (fr) * | 2004-05-25 | 2006-08-04 | Sanofi Synthelabo | Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique |
EP1630158A1 (en) | 2004-08-18 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | 5-HT7 receptor antagonists |
ES2257168B1 (es) | 2004-08-18 | 2007-06-01 | Laboratorios Del Dr Esteve, S.A. | Ligandos del receptor 5-ht7. |
US20080261999A1 (en) | 2005-03-04 | 2008-10-23 | Fionna Mitchell Martin | Azabicycloalkane Derivatives Useful as Nicotinic Acetylcholine Receptor Agonists |
EP1790646A1 (fr) * | 2005-11-24 | 2007-05-30 | Sanofi-Aventis | Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3. |
-
2004
- 2004-05-25 FR FR0405607A patent/FR2870846B1/fr not_active Expired - Lifetime
-
2005
- 2005-05-23 HN HN2005000239A patent/HN2005000239A/es unknown
- 2005-05-23 AR ARP050102107A patent/AR050250A1/es not_active Application Discontinuation
- 2005-05-23 JO JO200571A patent/JO2877B1/en active
- 2005-05-23 PE PE2005000566A patent/PE20060273A1/es not_active Application Discontinuation
- 2005-05-24 SV SV2005002126A patent/SV2006002126A/es active IP Right Grant
- 2005-05-24 NZ NZ551509A patent/NZ551509A/en not_active IP Right Cessation
- 2005-05-24 KR KR1020067024780A patent/KR101176675B1/ko active IP Right Grant
- 2005-05-24 CA CA2565293A patent/CA2565293C/fr not_active Expired - Fee Related
- 2005-05-24 DK DK05772938.6T patent/DK1753725T3/da active
- 2005-05-24 TW TW094116907A patent/TWI360540B/zh not_active IP Right Cessation
- 2005-05-24 AU AU2005250197A patent/AU2005250197B2/en not_active Ceased
- 2005-05-24 GT GT200500126A patent/GT200500126A/es unknown
- 2005-05-24 PL PL05772938T patent/PL1753725T3/pl unknown
- 2005-05-24 MY MYPI20052337A patent/MY148980A/en unknown
- 2005-05-24 MX MXPA06013629A patent/MXPA06013629A/es active IP Right Grant
- 2005-05-24 CN CN200580016856.7A patent/CN1956962B/zh active Active
- 2005-05-24 ES ES05772938T patent/ES2407140T3/es active Active
- 2005-05-24 EA EA200602176A patent/EA010234B1/ru not_active IP Right Cessation
- 2005-05-24 BR BRPI0511581-7A patent/BRPI0511581A/pt not_active Application Discontinuation
- 2005-05-24 EP EP05772938A patent/EP1753725B1/fr active Active
- 2005-05-24 UY UY28917A patent/UY28917A1/es not_active Application Discontinuation
- 2005-05-24 PT PT57729386T patent/PT1753725E/pt unknown
- 2005-05-24 SI SI200531708T patent/SI1753725T1/sl unknown
- 2005-05-24 UA UAA200613640A patent/UA84771C2/uk unknown
- 2005-05-24 WO PCT/FR2005/001279 patent/WO2005118547A1/fr active Application Filing
- 2005-05-24 ZA ZA200609820A patent/ZA200609820B/xx unknown
- 2005-05-24 JP JP2007514007A patent/JP4861979B2/ja active Active
- 2005-05-25 DO DO2005000103A patent/DOP2005000103A/es unknown
- 2005-05-25 PA PA20058634501A patent/PA8634501A1/es unknown
-
2006
- 2006-11-02 IL IL179021A patent/IL179021A/en not_active IP Right Cessation
- 2006-11-03 TN TNP2006000356A patent/TNSN06356A1/en unknown
- 2006-11-07 CR CR8735A patent/CR8735A/es unknown
- 2006-11-15 US US11/559,929 patent/US7833999B2/en active Active
- 2006-11-22 EC EC2006007020A patent/ECSP067020A/es unknown
- 2006-11-23 NI NI200600279A patent/NI200600279A/es unknown
- 2006-12-04 MA MA29510A patent/MA28720B1/fr unknown
- 2006-12-19 NO NO20065918A patent/NO338104B1/no not_active IP Right Cessation
-
2007
- 2007-10-24 HK HK07111466.5A patent/HK1106229A1/xx not_active IP Right Cessation
-
2010
- 2010-10-08 US US12/901,063 patent/US8273733B2/en active Active
-
2012
- 2012-08-24 US US13/593,832 patent/US8524700B2/en active Active
-
2013
- 2013-05-16 HR HRP20130431TT patent/HRP20130431T1/hr unknown
- 2013-05-24 CY CY20131100411T patent/CY1114240T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8634501A1 (es) | Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica | |
ECSP10010060A (es) | Derivados de pirazol sustituídos | |
CO5700772A2 (es) | Composiciones de pirazole utiles como inhibidores de gsk-3 | |
MX2007004215A (es) | Proceso para la sintesis de 4-(3-metansulfonilfenil)-1-n- propilpiperidina. | |
EA200801607A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
AR045234A1 (es) | Metodo para producir derivados del almidon de hidroxialquilo y composiciones farmaceuticas que los contienen. | |
MX2009004910A (es) | Compuestos sustituidos de 3-isobutil-9,10-dimetoxi-1,3,4,6,7,11-b- hexahidro-2h-pirido[2,1-a] isoquinolin-2-ol y métodos que se relacionan al mismo. | |
CL2009000127A1 (es) | Compuestos derivados de [indol, azaindol]-2-carboxamida sustituidos con un grupo silanilo; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso en el tratamiento del dolor, inflamacion, trastornos metabolicos, entre otras enfermedades mediadas por la modulacion del receptor trpv1. | |
PA8797301A1 (es) | Derivados de nicotinamida, su preparacion y su aplicacion en terapeutica | |
CY1107846T1 (el) | Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες | |
NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
MXPA05009059A (es) | Derivados de heteroarilcarbamoilbenceno. | |
BRPI0509258A8 (pt) | composto de 8-oxoadenina 9-substituída | |
EA200400387A1 (ru) | Азабициклические замещённые конденсированные гетероарильные соединения для лечения заболеваний | |
CO6220949A2 (es) | Derivados pirazolicos como inhibidores de la 11 beta -hsd1 | |
DOP2005000091A (es) | (4-metoxi-7-morfolin-4-il-benzotiazol-2-il) amida del acido 4-hidroxi-4-metil-piperidin-1-carboxilico | |
PE20091842A1 (es) | Pirrolidinonas como activadores de glucoquinasa | |
TW200740795A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
PL1831239T3 (pl) | Sposób wytwarzania gamma-laktonu kwasu 17-hydroksy-6 beta, 7 beta,15 beta, 16 beta-bismetyleno-17 alpha-pregn-4-en-3-ono-21-karboksylowego i związki pośrednie kluczowe dla tego sposobu | |
AR057555A1 (es) | Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo | |
TW200738681A (en) | Isoquinoline and benzo[h]isoquinoline derivatives, their preparation and their use in therapeutics | |
UY29054A1 (es) | Derivados de pirro, su preparación y su aplicación en terapeutica | |
ECSP045222A (es) | INHIBIDORES DE LA ADHESION CELULAR MEDIADA POR INTEGRINA aLb2 | |
ATE448216T1 (de) | Tetralin- und indanderivate und anwendungen davon | |
WO2007006922A3 (fr) | Nouveaux derives 1h-indole-pyridinecarboxamides et 1h-indole-piperidinecarboxamide et leur utilisation comme inducteurs de tyrosine hydroxylase |